NCT03355040

Brief Summary

A french study published in 2015 (DAME) showed a decrease of shoulder dystocia and an increase of spontaneous vaginal delivery when the non insulin-treated diabetes patients with large-for-date fetus were induced. This new protocole was introduced in Montpellier University Hospital delivery room. The aim of this study is to evaluate the protocole in Montpellier hospital and to compare our results with the DAME results.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

October 12, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 28, 2017

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
Last Updated

April 18, 2019

Status Verified

April 1, 2019

Enrollment Period

2.8 years

First QC Date

October 12, 2017

Last Update Submit

April 17, 2019

Conditions

Keywords

shoulder dystociamaternal and neonatal morbidity

Outcome Measures

Primary Outcomes (5)

  • number of shoulder dystocia

    number of shoulder dystocia

    1 day (after delivery)

  • number of Clavicle fracture

    number of Clavicle fracture

    1 day (after delivery)

  • number of Brachial plexus injury

    number of Brachial plexus injury

    1 day (after delivery)

  • number of Intracranial heamorrhage

    number of Intracranial heamorrhage

    1 day (after delivery)

  • number of Neonatal death

    number of Neonatal death

    1 day (after delivery)

Secondary Outcomes (8)

  • Number of Cord blood pH< 7,10 for the newborn

    1 day (after delivery)

  • Number of apgar < 7 at 5 min for the newborn

    1 day (after delivery)

  • Number of admission to neonatal intensive care unit for the newborn

    1 day (after delivery)

  • Number of highest bilirubin concentration for the newborn

    1 day (after delivery)

  • Number of Caesarean for the patient

    1 day (after delivery)

  • +3 more secondary outcomes

Interventions

induction of labour

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Pregnant patients non diabetic or diabetic without insulin-treatment with large for date fœtus.

You may qualify if:

  • Age \>18 years old Single pregnancy Cephalic presentation no contraindications to planned vaginal delivery no fœtal pathology
  • Large-for-date foetus (estimated weight \> 95%) :
  • Clinically suspeted or estilated weight \>90% at the 3 trimester ultrasound
  • Estimated fœtal weight :
  • \> 3500g at 36 GA \> 3700g at 37 GA \> 3900g at 38 GA

You may not qualify if:

  • Age \<18 yeaurs old contraindications to vaginal delivery insulin-trated diabetics or imbalance diabetics. neonatal trauma or shoulder dystocia, severe urinary or faecal incontinence.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Shoulder Dystocia

Interventions

Labor, Induced

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesDystociaObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Delivery, ObstetricObstetric Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • florent FUCHS

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2017

First Posted

November 28, 2017

Study Start

April 1, 2016

Primary Completion

January 1, 2019

Study Completion

January 1, 2019

Last Updated

April 18, 2019

Record last verified: 2019-04

Locations